Michael Allen Jerman Alaunos Therapeutics, Inc. (TCRT) insider trading activity

Michael Allen Jerman is of Alaunos Therapeutics, Inc.. Currently has a direct ownership of 4,183 shares of TCRT, which is worth approximately $12,423. The most recent transaction as insider was on Nov 21, 2025, when has been sold 4,183 shares (Common Stock) at a price of $3.16 per share, resulting in proceeds of $13,218. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.18K

n/a 3M change

n/a 12M change

Total Value Held $12,423

Michael Allen Jerman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Nov 21 2025	BUY Grant, award, or other acquisition	$13,218 $3.16 p/Share	4,183 Added 50.0%	4,183 Common Stock

Also insider at

INTI

Inhibitor Therapeutics, Inc. Healthcare

Director

MIRA

MIRA PHARMACEUTICALS, INC.

Director

TELO

Telomir Pharmaceuticals, Inc.

Director

MAJ